Cardioprotective effect of pentacyclic triterpene, lupeol and its ester on cyclophosphamide-induced oxidative stress

Human and Experimental Toxicology

Volumn 24, Issue 6, 2005, Pages 313-318

  Sudharsan, P T ^a   Mythili, Y ^a   Selvakumar, E ^a   Varalakshmi, P ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Antioxidants; Cardiotoxicity; Cyclophosphamide; Lipid peroxidation; Lupeol; Lupeol linoleate

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); ALKYLATING AGENT; ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; CATALASE; CRATAEVA NURVALA EXTRACT; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYTOCHROME P450; ESTER DERIVATIVE; FREE RADICAL; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; LACTATE DEHYDROGENASE; LINOLEIC ACID; LIPID PEROXIDE; LUPEOL; LUPEOL LINOLEATE; PENTACYCLIC TRITERPENE; PLANT EXTRACT; PYROGALLOL; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BARK; CARDIOTOXICITY; CELL PROTECTION; CONTROLLED STUDY; CRATAEVA NURVALA; DRUG EFFECT; DRUG ISOLATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; HEART PROTECTION; LIPID PEROXIDATION; MALE; MEDICINAL PLANT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RAT STRAIN; SINGLE DRUG DOSE; TISSUE LEVEL;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; CAPPARACEAE; CARDIOTONIC AGENTS; CATALASE; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYTOSOL; ESTERS; GLUTATHIONE; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; INJECTIONS, INTRAPERITONEAL; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; MALE; MUTAGENS; MYOCARDIUM; OXIDATIVE STRESS; PLANT BARK; PLANT EXTRACTS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TRITERPENES;

CRATAEVA NURVALA;

EID: 21744436597     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327105ht530oa     Document Type: Article

References (43)

1. Dollery C. Therapeutic drugs. Edinburgh: Churchill Livingstone, 1999: 349-53.
2. Santos GW, Sensenbrenner LL, Burke PJ, Colvin M, Owens AH Jr, Bias WB. Marrow transplantation in man following cyclophosphamide. Transplant Proc 1971; 2: 400-404.
3. Lipp HP. Cardiotoxicity of cytotoxic drugs. In Lipp HP ed. Anticancer drug toxicity. Prevention, management and clinical pharmacokinetics. New York: Marcel Dekker Inc, 1999: 471-88.
4. Shanholtz C. Acute life-threatening toxicity of cancer treatment. Crit Care Clin 2001; 17: 483-502.
5. Fraiser LH, Kanekal S, Kehrer JP. Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs 1991; 42: 781-95.
6. Lee LK, Harman GS, Hohl RJ, Gingrieh RD. Fatal cyclophosphamide cardiomyopathy: its clinical course and treatment. Bone Marrow Transplant 1996; 18: 573-77.
7. Colombo P, Gunnarsson K, Latropoulos M, Brughera M. Toxicological testing of cytotoxic drugs. Int J Oncol 2001; 19: 1021-28.
8. Patočka J. Biologically active pentacyclic triterpenes and their current medicine signification. J Appl Biomed 2003; 1: 7-12.
9. Geetha T, Varalakshmi P. Anti inflammatory activity of lupeol and lupeol linoleate in adjuvant induced arthritis. Fitoterapia 1998; 69: 13-19.
10. Vidya L, Malini MM, Varalakshmi P. Effect of pentacyclic triterpenes on oxalate induced changes in rat erythrocytes. Pharmacol Res 2000; 42: 314-16.
11. Foulon T, Richard MJ, Payen N, Bourrain JL, Beani JC, Laporte F, Hadjian A. Effects of fish oil fatty acids on plasma lipids and lipoproteins and oxidants-antioxidants imbalance in healthy subjects. Scand J Clin Lab Invest 1999; 59: 239-48.
12. Kikugawa K. Effect of ω 6 and ω 3 fatty acid supplementation on rat tissue lipid peroxidation. World Rev Nutr Diet 2001; 88: 28-34.
13. Sunitha M, Nagaraj M, Varalakshmi P. Hepatoprotective effect of lupeol and lupeol linoleate on tissue antioxidant defense system in cadmium-induced hepatotoxicity in rats. Fitoterapia 2001; 72: 516-23.
14. Baskar R, Malini MM, Varalakshmi P, Balakrishna K, Bhima Rao, R. Effect of lupeol isolated from Crataeva nurvala stem bark against free radical induced toxicity in experimental urolithiasis. Fitoterapia 1996; 67: 121-25.
15. Kweifio-Okai G, Field B, Rumble BA, Macrides TA, De Munk F. Esterification improves anti-arthritic effectiveness of Lupeol. Drug Development Research 1995; 35: 137-141.
16. Okinaka S, Sugita H, Mamoi T, Toyukura Y, Watanabe T, Ebashi F, Ebashi S. Cysteine-stimulated serum creatine kinase in health and disease. J Lab Clin Med 1964; 64: 299-305.
17. King J. Dehydrogenases or oxidoreductases, lactate dehydrogenase. In Van D ed. Practical clinical enzymology. London: Nostrand Company Ltd, 1965: 83-93.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1965; 193: 265-75.
19. Hogberg J, Larson RE, Kristoferson A, Orrenius S. NADPH-dependent reductase solubilized from microsomes by peroxidation and its activity. Biochem Biophys Res Commun 1974; 56: 836-42.
20. Marklund S, Marklund G. Involvement of superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47: 469-74.
21. Sinha AK. Colorimetric assay of catalase. Anal Biochem 1972; 47: 389-95.
22. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973; 179: 588-90.
23. Staal GEJ, Visser J, Veeger C. Purification and properties of glutathione reductase of human erythrocytes. Biochim Biophys Acta 1969; 185: 39-48.
24. Beutler E. Active transport of glutathione disulphide from erythrocytes. In Larson A, Orrenius S, Holmgrem A, Mannerwik B eds. Functions of glutathione: biochemical, physiological, toxicological and clinical aspects. New York: Raven Press, 1983: 65.
25. Habig WH, Pabst MJ, Jacob WB. Glutathione-S-transferase. The first enzymatic step in mercapturic acid formation. J Biol Chem 1973; 249: 7130-39.
26. Moron MS, Defierre JW, Mannervik B. Levels of glutathione, glutathione reductase, glutathione-s-transferase activities in rat lung and liver. Biochim Biophys Acta 1979; 582: 67-78.
27. Omaye ST, Turnbull JD, Sauberlich HE. Selected methods for the determination of ascorbic acid in animal cell, tissues and fluids. Methods Enzymol 1971; 62: 1-11.
28. Desai ID. Vitamin E analysis methods for animal tissues. Methods Enzymol 1984; 105: 138-47.
29. Ferguson LR, Pearson AE. The clinical use of mutagenic anticancer drugs. Mutat Res 1966; 355: 1-12.
30. Moore MJ. Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet 1991; 20: 194-208.
31. Singh J, Garg KN, Garg D, Chugh K, Lal H. Effect of aspartate and glutamate on experimental myocardial infarction in rats. Indian J Exp Biol 1989; 27: 621-24.
32. Buja LM, Ferrans VJ, Graw RG. Cardiac pathologic findings in patients treated with bone marrow transplantation. Hum Pathol 1976; 7: 17-45.
33. Gottdiener JS, Applebaum FR, Ferrans VJ, Deisseroth A, Ziegler J. Cardiotoxicity associated with high dose cyclophosphamide therapy. Arch Intern Med 1981; 141: 758-63.
34. Bergendi L, Benes L, Durackova Z, Ferencik M. Chemistry, physiology and pathology of free radicals. Life Sci 1999; 65: 1865-74.
35. Pigeolet E, Corbisier P, Houbion A, Lambert D, Michiels C, Raes M, Zachary MD, Remacle J. Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech Ageing Dev 1990; 51: 283-97.
36. Bray TM, Taylor CG. Tissue glutathione, nutrition and oxidative stress. Can J Physiol Pharmacol 1993; 71: 746-51.
37. Friedman HS, Colvin OM, Asiaka K, Popp J, Bossen EH, Reimer KA, Powell JB, Hilton J, Gross SS, Levi R, Bigner DD, Griffith OW. Glutathione protects cardiac and skeletal muscle from cyclophosphamide induced damage. Cancer Res 1990; 50: 2455-62.
38. Levine ES, Friedman HS, Griffith OW, Colvin OM, Raynor JH, Lieberman M. Cardiac cell toxicity induced by 4-hydroperoxycyclophosphamide is modulated by glutathione. Cardiovasc Res 1993; 27: 1248-53.
39. Ishikawa T, Esterbauer H, Sies H. Role of cardiac glutathione transferase and of the glutathione S-conjugate export system in biotransformation of 4-hydroxynonenal in the heart. J Biol Chem 1986; 261: 1576-81.
40. Mize CE, Langdon RG. Hepatic glutathione reductase. I. Purification and general kinetic properties. J Biol Chem 1962; 237: 1589-95.
41. Yoshida A, Haung IY. Structure of human glucose-6-phosphate dehydrogenase. In Yoshida A, Beutler E eds. Glucose-6-phosphate dehydrogenase. New York: Academic Press, 1986: 473-82.
42. Marchioli R. Antioxidants vitamins and prevention of cardiovascular disease; laboratory, epidemiological and clinical trial data. Pharmacol Res 1999; 40: 227-38.
43. Lee IM. Antioxidant vitamins in the prevention of cancer. Proc Assoc Am Physicians 1999; 111: 10-15.